Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials

, Emmanuel Musisi, Adam Wyness, Wilber Sabiiti

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Respiratory tract microbiota has been described as the gatekeeper for respiratory health. We aimed to assess the impact of standard-of-care and experimental anti-tuberculosis treatment regimens on the respiratory microbiome and implications for treatment outcomes.
Original languageEnglish
Pages (from-to)e913-e922
Number of pages10
JournalThe Lancet Microbe
Volume4
Issue number11
DOIs
Publication statusPublished - 1 Nov 2023

Fingerprint

Dive into the research topics of 'Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials'. Together they form a unique fingerprint.

Cite this